Get a glimpse into our company and investor data—powered by the PitchBook Platform
NitroMed (BiDil Drug Business)
Buyout/LBOLATEST DEAL TYPE
Operator of a specialty pharmaceutical company. The company provides research and development efforts focuses on major diseases that are characterized by a deficiency in nitric oxide such as cardiovascular and inflammatory diseases.